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Abstract We recently showed that FliC of Salmonella enter-
itidis increased human L-defensin-2 (hBD-2) expression, and now
describe the signaling responsible pathway. FliC increased the
intracellular Ca2+ concentration ([Ca2+]in) in Caco-2 cells. The
[Ca2+]in increase induced by FliC was prevented by U73122 and
heparin, but not by chelating extracellular Ca2+ or pertussis
toxin. The FliC-induced increase in hBD-2 promoter activity via
nuclear factor UB (NF-UB) was also inhibited by chelation of
intracellular Ca2+ or by U73122. We conclude that FliC
increased [Ca2+]in via inositol 1,4,5-trisphosphate, which was
followed by up-regulating hBD-2 mRNA expression via an NF-
UB-dependent pathway. ß 2001 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Salmonella species are Gram-negative organisms that cause
gastroenteritis and enteric fever in humans. These symptoms
appeared to result from the mucosal in£ammatory response
induced by this pathogen.
We recently reported that FliC of Salmonella enteritidis in-
creased human L-defensin-2 (hBD-2) mRNA levels and time
course correlated with nuclear factor UB (NF-UB) activation
in a human colon carcinoma (Caco-2) cell line [1]. Bacterial
£agella ¢lament structural proteins have also been implicated
in the production of cytokines [2,3]. Puri¢ed phase 1 Salmo-
nella £agellin and FliC synthesized in Escherichia coli each
enhanced release of tumor necrosis factor K and interleukin
(IL)-1 from a human promonocytic cell line [2,3]. Salmonella
typhimurium £agella impaired antigen uptake and presenta-
tion by human macrophages [4], and induced a cytokine pro-
duction cascade in these cells [5]. Key factors in activating
cytokine production were the increases in intracellular Ca2
concentration ([Ca2]in) and subsequent NF-UB activation.
Intracellular Ca2 mobilization is a widely used signaling
mechanism and there are many reports of Salmonella-induced
increases in [Ca2]in in model epithelium. Pace et al. demon-
strated that blocking S. typhimurium invasion with cytochala-
sin D, an inhibitor of actin polymerization, did not prevent an
increase in [Ca2]in [6] and that the invasion-defective S. typh-
imurium mutant Hilv, which lacks the type III secretion ap-
paratus, was also able to increase [Ca2]in leading to NF-UB
activation and IL-8 secretion [7]. We postulated that the NF-
UB-dependent stimulation of hBD-2 mRNA expression in-
duced by FliC of S. enteritidis might result from increases in
[Ca2]in.
As reported here, we found that FliC of S. enteritidis did,
indeed, stimulate [Ca2]in, apparently via inositol 1,4,5-tris-
phosphate (IP3) leading to increase hBD-2 mRNA expression.
2. Materials and methods
2.1. FliC from S. enteritidis cells
FliC of S. enteritidis was prepared as previously described with the
following modi¢cation [1,8]. S. enteritidis was grown on tryptic soy
agar broth for 16 h at 37‡C, and was pelleted by centrifugation
(5000Ug, 30 min, 4‡C) and suspended in phosphate-bu¡ered saline
(PBS), which was adjusted to pH 2 with 1 M HCl and maintained at
that pH with constant stirring for 30 min at room temperature. After
centrifugation at 100 000Ug for 1 h at 4‡C, the pH of the supernatant
containing detached monomeric £agellin was adjusted to 7.2 with 1 M
NaOH and (NH4)2SO4 was added to 65% saturation. After incuba-
tion overnight at 4‡C, the solution was centrifuged (15 000Ug, 15 min,
4‡C). The precipitate was dissolved in distilled water, dialyzed against
distilled water, heated at 65‡C for 15 min and centrifuged at
100 000Ug for 1 h at 4‡C. To the supernatant solid (NH4)2SO4 was
added to a concentration of 0.7 M. After storage overnight at 4‡C,
polymerized FliC was collected by centrifugation at 100 000Ug for 1 h
at 4‡C and dissolved in PBS.
2.2. Preparation of anti-FliC IgG
Anti-FliC IgG was prepared as previously described. Brie£y, a pep-
tide, NH2-QFTFDDKTKNESAKL (amino acids 339^353) of S. en-
teritidis FliC with an added carboxy-terminal Cys, was synthesized
and coupled to keyhole limpet hemocyanin (KLH). Rabbits were
immunized with peptide-coupled KLH (200 Wg) or puri¢ed FliC pro-
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tein (40 Wg) in complete Freund adjuvant (1:1 v/v) subcutaneously on
day 0, day 21, and at weekly intervals thereafter until the desired
serum titer against the peptide was reached. Rabbits were bled 7
weeks after the ¢rst injection.
2.3. Caco-2 cells in culture
Caco-2 cells, a colonic epithelial cell line, were purchased from the
American Type Culture Collection (MD, USA). Cells were main-
tained in Dulbecco’s modi¢ed Eagle’s medium (DMEM) supple-
mented with 10% (v/v) fetal bovine serum and 100 U/ml gentamicin.
The media and supplements were purchased from Gibco BRL (MD,
USA). Cells were grown in 75-cm2 £asks in an atmosphere of 5% CO2
at 37‡C with medium changed twice weekly.
2.4. Intracellular Ca2+ measurements
The [Ca2]in was assessed by micro£uorometry, using the £uores-
cent dye Fura-2/AM (1-(2-(5P-carboxyoxazol-2P-yl)-6-aminobenzofur-
an-5-oxy)-2(2ino-5P-methyl-phenoxy)ethane-N,N,NP,NP-tetraacetic
acid, pentaacetoxy methyl ester) at excitation wavelengths of 340 nm
and 380 nm and at an emission wavelength of 510 nm with an AR-
GUS-50/CA system (Hamamatsu Photonics, Japan). Cells were grown
on round coverslips (12 mm) for 2 days, after which they were incu-
bated with 2 WM Fura-2/AM (Molecular Probes, OR, USA) for 30
min and washed twice with PBS, before coverslips were inserted into
the chamber for measuring [Ca2]in at 37‡C.
2.5. Heparin loading into Caco-2 cells
Heparin (molecular weight 2000V5000) was loaded into the Caco-2
cells using In£ux1 pinocytic cell loading reagent (Molecular Probes,
OR, USA). Brie£y, Caco-2 cells growing on coverslip were incubated
in hypertonic loading medium with 2 WM Fura-2/AM with or without
heparin (5 mg/ml) at 37‡C for 10 min, and were incubated for 2 min in
Fig. 1. E¡ects of FliC on [Ca2]in of Caco-2 cells. A: Time courses
of [Ca2]in in Caco-2 cells after addition of FliC and/or anti-FliC at
the indicated time. (square) No addition; (circle) FliC; (triangle)
FliC plus anti-FliC. # Signi¢cant di¡erence, P6 0.05 vs. (square).
B: E¡ect of FliC concentration on [Ca2]in of Caco-2 cells. Data
are means þ S.D. (n = 10).
Fig. 2. E¡ect of Ca2-free medium on FliC-induced increase in
[Ca2]in. CaCl2 was omitted from the medium and 1 mM EGTA
was added. (circle) FliC was added to cells at the indicated time.
(triangle) No addition of FliC. Data are means þ S.D. (n = 10). #
Signi¢cant di¡erence, P6 0.05 vs. (triangle).
Fig. 3. A: E¡ects of ryanodine and U73122 on [Ca2]in of Caco-2
cells treated with FliC. (circle) FliC was added to cells at the indi-
cated time (positive control). (rhomb) Ryanodine (10 WM) or (trian-
gle) U73122 (1 WM) was added to cells 30 min before. Data are ex-
pressed as means þ S.D. (n = 10). # Signi¢cant di¡erence, P6 0.05
vs. positive control. B: E¡ect of PTX on [Ca2]in response to FliC.
(circle) FliC was added to cells at the indicated time. * Signi¢cant
di¡erence, P6 0.05 vs. (triangle). (triangle) No addition of FliC.
(rhomb) Cells were incubated with PTX (200 ng/ml) for 24 h before
the addition of FliC at the indicated time. Data are means þ S.D.
(n = 10). # Signi¢cant di¡erence, P6 0.05 vs. (triangle).
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the hypotonic lysis medium with 2 WM Fura-2/AM with or without
heparin (5 mg/ml), before washing twice with PBS.
2.6. Luciferase assay
To assess hBD-2 promoter activity, Caco-2 cells were distributed in
24-well plates (1U105 cells in 1 ml of DMEM per well) and incubated
for 24 h at 37‡C. The hBD-2 promoter or 5P-deletion constructs of the
hBD-2 promoter pGL3-2110, each sample 2.5 Wg, linked to a lucifer-
ase reporter gene [9] were incubated with 0.5 Wg of (internal control) a
Renilla luciferase expression vector (pRL-TK) and 10 Wl of 3.2 mM
dendritic poly-(L-lysine) (KG6) [10] in 250 Wl of fetal calf serum
(FCS)-free DMEM for 15 min at room temperature before the mix-
ture containing DNA^peptide complexes was added to Caco-2 cells
and incubated for 3 h at 37‡C. 1 ml of DMEM was added 24 h after
culture medium was replaced with 1 ml of fresh FCS-free DMEM.
Samples (300 Wl) of the preparation to be assayed were then added.
After incubation for 6 h at 37‡C, cells were washed with 1 ml of PBS
and lysed in 100 Wl of lysis bu¡er (Tokyo Ink Co., Japan). After 15
min at room temperature, the lysate was centrifuged (18 000Ug,
5 min, 4‡C). Luciferase activity of the supernatant, measured using
a luminometer (Berthold), was normalized to activity of the control
Renilla luciferase activity.
2.7. Immunocytochemical staining
Caco-2 cells were grown on coverslips (18U18 mm) for 2 days.
After treatment of the cells with FliC, BAPTA-AM (1,2-bis(2-amino-
phenoxy)-ethane-N,N,NP,NP-tetraacetic acid tetrakis(acetoxymethyl
ester)), or U73122, they were washed three times with PBS and ¢xed
with 3.5% formaldehyde in PBS for 20 min. After washing with PBS,
the cells were treated with 0.01% (v/v) Triton X-100 for 30 s, and then
they were incubated with 4% milk casein for 1 h. After washing, the
cells were incubated with 200 times diluted rabbit antibody against
p65 (Santa Cruz, CA, USA) for 1 h at room temperature. The cells
were washed again and incubated for 1 h with 500 times diluted Alexa
Fluor0 594 conjugated goat anti-rabbit IgG (Molecular Probes, OR,
USA).
3. Results
3.1. FliC increased intracellular free Ca2+
[Ca2]in in Caco-2 cells increased at a relatively constant
Fig. 4. E¡ect of heparin on [Ca2]in response to FliC. (circle) FliC
was added to cells at the indicated time. (triangle) No additions.
(rhomb) Heparin was delivered into cells by pinocytosis (see Section
2) before addition of FliC. Data are means þ S.D. (n = 10). # Signi¢-
cant di¡erence, P6 0.05 vs. (rhomb).
Fig. 5. E¡ect of BAPTA-AM or U73122 on NF-UB distribution. Cells were incubated for 30 min with the indicated concentration of BAPTA-
AM or U73122 before addition of FliC (2 Wg/ml). The cells were ¢xed 3 h later. A^D: Fluorescence photomicrograph. E^H: Photomicrograph
on each of the same area as in A^D. I: Rate of the cells that p65 translocated to nucleus.
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rate for 15 min after the addition of FliC (2 Wg/ml) and was
slowly decreased after. This e¡ect was inhibited by prior ad-
dition of ant-FliC antibody (1.5 Wg/ml) (Fig. 1A), con¢rming
that FliC increased [Ca2]in in Caco-2 cells. The magnitude of
the [Ca2]in increase at 15 min was dependent on FliC con-
centration (Fig. 1B).
3.2. Signaling pathway for FliC-induced intracellular Ca2+
mobilization
The FliC e¡ect on [Ca2]in persisted in Ca2-free medium
containing 1 mM EGTA (Fig. 2), suggesting that the increase
in [Ca2]in was due to release from intracellular Ca2 stores.
Two well-characterized pathways evoked release from inter-
nal Ca2 stores, ryanodine receptor- and IP3 receptor-medi-
ated pathways. Ryanodine can deplete the ryanodine-sensitive
Ca2 stores in cells [11], however, 10 WM ryanodine failed to
inhibit the [Ca2]in increase induced by FliC (Fig. 3A). To
assess involvement of the IP3 receptor-mediated pathway in
FliC-induced release from internal Ca2 stores, the cells were
incubated with pertussis toxin (PTX; 200 ng/ml) for 24 h
before experiments (Fig. 3B). PTX treatment had no
[Ca2]in response to FliC, suggesting that the FliC-evoked
increase in [Ca2]in was not mediated by a PTX-sensitive G
protein. U73122, a phospholipase C (PLC) inhibitor that has
been reported to inhibit PLC-mediated e¡ects in several cell
types [12,13], completely prevented the FliC-mediated [Ca2]in
increase (Fig. 3A). Heparin, a known inhibitor against IP3
receptors [14,15], was delivered into the Caco-2 cells using
pinocytosis (see Section 2) and completely inhibited the e¡ect
on [Ca2]in (Fig. 4).
3.3. hBD-2 promoter activity via NF-UB
FliC induced the translocation of NF-UB to nucleus (Fig.
5). On the other hand, treatment with BAPTA-AM and
U73122 prevented the translocation of NF-UB to nucleus.
These results indicated that the translocation of NF-UB to
nucleus induced by FliC was PLC- and [Ca2]in-dependent.
To assess FliC-induced hBD-2 promoter activity via NF-UB
was measured. Activation of the hBD-2 promoter via NF-UB
was inhibited by [Ca2]in chelation with BAPTA-AM or
U73122 in a dose-dependent manner (Fig. 6), consistent
with the conclusion that [Ca2]in increases were essential for
hBD-2 production.
4. Discussion
Puri¢ed FliC from S. enteritidis increased [Ca2]in in Caco-
2 cells via a mechanism that apparently involves PLC-depen-
dent stimulation of IP3 production and release of Ca2 from
ryanodine-insensitive intracellular Ca2 stores. The pathways
that induce Ca2 release from intracellular Ca2 stores are
well-characterized in many cells. The signals are often initi-
ated via heptahelical G protein-coupled receptors, but can
also be initiated by cell-surface molecules that lack an intra-
cellular domain (for example, via glycophosphatidyl inositide-
anchored FcQ receptors on human neutrophils), presumably
by clustering signaling molecules [16]. Recently, it was re-
ported that the Toll-like receptor 5 was a receptor for S. typh-
imurium £agellin [17]. Although Toll-like receptor 5 may be
also a receptor for FliC of S. enteritidis, recent knowledge
about Toll-like receptor 5 cannot explain the pathways of
[Ca2]in increases, clearly [18^22]. But, it seems reasonable
that a receptor-mediated mechanism of these types could me-
diate FliC of S. enteritidis-induced [Ca2]in mobilization. Re-
ceptor-mediated events have been reported in other systems.
In airway epithelial cells, Pseudomonas aeruginosa activated
NF-UB via interaction with the cellular pilin receptor [22].
FliC-induced [Ca2]in mobilization was PTX-insensitive (Fig.
3B). The existence of PTX-insensitive G protein^PLC^IP3 sig-
naling in a P2Y purine receptor signaling pathway was corre-
lated with a PTX-insensitive G protein of the Gq/11 family
[23,24]. It seems likely that a protein of the Gq/11 family is
involved in FliC-mediated [Ca2]in mobilization but this re-
mains to be established.
The increase with [Ca2]in initiated by S. enteritidis FliC
occurred rather slowly. The [Ca2]in increases induced by S.
typhimurium [7,25] and by activation of Toll-like receptor RP-
105 in B cells [26] were similarly slow. In muscle cell, however,
increase in [Ca2]in coupled to PLC-dependent stimulation of
IP3 production and release of Ca2 from intracellular stores
are very rapid [27,28]. On the other hand, the recently re-
ported increases in [Ca2]in coupled to PLC activity to stim-
ulate IP3 production and release of Ca2 from intracellular
Ca2 stores in primary neurons were slow [29]. The reasons
for the very di¡erent kinetics of seemingly similar mechanisms
of [Ca2]in increases remain to be determined.
Gerwirts et al. indicated that S. typhimurium infections in-
creased [Ca2]in during 3 h, when extracellular Ca2 was che-
lated by EGTA (named ‘initial’ increase). When extracellular
Fig. 6. E¡ect of BAPTA-AM or U73122 on hBD-2 production.
Cells were incubated for 30 min with the indicated concentration of
BAPTA-AM or U73122 before addition of FliC (2 Wg/ml). Lucifer-
ase activity was determined 3 h later. A: BAPTA-AM. B: U73122.
Data are means þ S.D. of values from three separate experiments
with assays in duplicate.
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Ca2 was chelated, however, the [Ca2]in increases were small-
er 3^8 h following Salmonella infections [7]. Because, FliC-
mediated [Ca2]in increases were not inhibited by chelating
extracellular Ca2 and did not return to baseline after about
30 min in this study. These changes in [Ca2]in are consistent
with the ‘initial’ phase (during the ¢rst 3 h after Salmonella
infection as described by Gerwirts et al.). Moreover, we dem-
onstrated that FliC mediated [Ca2]in increases, which are
consistent with the ‘initial’ phase of [Ca2]in increases up-
regulated by hBD-2 mRNA expression via NF-UB activation.
Thus, the ‘initial’ increases in [Ca2]in are a su⁄cient stimulus
to induce NF-UB activation.
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